Protocol performance metrics and resource utilization of phase II investigator-initiated trials

被引:0
|
作者
Durivage, H.
Bridges, K. D.
Sauers, J.
Wellons, M.
Baker, L.
机构
[1] Yale Univ, Sch Med, New Haven, CT USA
[2] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA
[3] Univ Minnesota, Masonic Can Ctr, Minneapolis, MN USA
[4] VCU Massey Canc Ctr, Richmond, VA USA
[5] Univ Texas Southwestern Simmons Canc Ctr, Dallas, TX USA
关键词
D O I
10.1200/jco.2010.28.15_suppl.6066
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
6066
引用
收藏
页数:1
相关论文
共 50 条
  • [1] DESIGNING INVESTIGATOR-INITIATED TRIALS
    Rosenfeld, Margaret
    PEDIATRIC PULMONOLOGY, 2012, 47 : 120 - 121
  • [2] MULTICENTER INVESTIGATOR-INITIATED TRIALS
    LENFANT, C
    HARLAN, W
    FRIEDMAN, LM
    CONTROLLED CLINICAL TRIALS, 1989, 10 (02): : 228 - 229
  • [3] Investigator-initiated trials are more impartial
    Bradley C. Johnston
    Sunita Vohra
    Nature, 2006, 443 : 144 - 144
  • [4] Investigator-initiated trials are more impartial
    Johnston, Bradley C.
    Vohra, Sunita
    NATURE, 2006, 443 (7108) : 144 - 144
  • [5] Protocol-writing support conferences for investigator-initiated clinical trials
    Goto, Masaya
    Muragaki, Yoshihiro
    Aruga, Atsushi
    OPEN ACCESS JOURNAL OF CLINICAL TRIALS, 2016, 8 : 7 - 12
  • [6] INSTITUTION / INVESTIGATOR-INITIATED CLINICAL TRIALS IN CANADA
    Sedgeworth, Jan
    Derewlany, Lidia
    JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2006, 13 (02): : E236 - E239
  • [7] INVESTIGATOR-INITIATED CLINICAL TRIALS - HOW TO BE SUCCESSFUL
    Allaart, C. F.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 22 - 22
  • [8] Quality assurance for investigator-initiated trials.
    Allent, Karen O.
    El Shayeb, Mohamed
    Saleh, Mansoor N.
    Fiveash, John B.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [9] The necessity of investigator-initiated trials in cardiothoracic surgery
    Velho, Tiago R.
    Guerra, Nuno
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2023, 64 (02)
  • [10] The development and challenges of Investigator-Initiated Trials (IITs) in China
    Minghuang Hong
    Zhao Yan
    Holistic Integrative Oncology, 3 (1):